Guidelines for the investigation of newly detected M-proteins and the management of monoclonal gammopathy of undetermined significance

These guidelines, written by the UK Myeloma Forum in conjunction with the Nordic Myeloma Study Group provide guidance for the effective clinical investigation of patients with newly detected paraprotein and the practical management of patients with monoclonal gammopathy of undetermined significance (MGUS).